New Hopes for Eating Disorder Treatment as Diabetes Drug Shows Surprising Results
Published on: Nov. 18, 2025, 2:02 a.m. | Source: Devdiscourse
Research reveals Eli Lilly's GLP-1 drug, tirzepatide, temporarily suppresses food cravings in a patient's brain reward center. While initial effects were promising, the impact faded over time. Results hint at potential future treatments for eating disorders, like binge-eating, if drugs are tailored for mental health impacts.
